Abionyx Pharma SA (ABNX) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	1.06M	1.06M	972.00K	972.00K
Cost of goods sold	945.50K	945.50K	819.00K	819.00K
Cost of revenue	945.50K	945.50K	819.00K	819.00K
Research and development expenses	346.00K	346.00K	413.00K	413.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	938.00K	938.00K	1.35M	1.35M
Operating expense	1.28M	1.28M	1.76M	1.76M
Total operating expenses	2.22M	2.22M	2.58M	2.58M
Operating income	-1.16M	-1.16M	-1.60M	-1.60M
Other non operating income	11.00K	11.00K	-19.00K	-19.00K
EBT including unusual items	-1.15M	-1.15M	-1.62M	-1.62M
EBT excluding unusual items	-1.15M	-1.15M	-1.62M	-1.62M
Income tax expense	4.00K	4.00K	500.00	500.00
Effective tax rate	-0.35%	-0.35%	-0.03%	-0.03%
Other operating expenses	-5.00K	-5.00K	-5.00K	-5.00K
Net income	-1.15M	-1.15M	-1.62M	-1.62M
Net profit margin	-108.82%	-108.82%	-166.87%	-166.87%
Earnings per share	-	-	-	-
Interest and investment income	8.50K	8.50K	18.50K	18.50K
Interest expense	-26.50K	-26.50K	-16.00K	-16.00K
Net interest expenses	-18.00K	-18.00K	2.50K	2.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.13M	-1.13M	-1.58M	-1.58M
Gain or loss from assets sale	-	-	-	-

Finance